Downregulation of CRABP2 Inhibit the Tumorigenesis of Hepatocellular Carcinoma In Vivo and In Vitro

Table 1

Correlations between CRABP2 expression and HCC patient clinicopathological characteristics undergo HCC surgical removal.

Clinical factor	CRABP2 expression		value
	Low expression ()	High expression ()
Age (y)
<60	9	15	0.955
≥60	13	21
Gender
Male	14	21	0.689
Female	8	15
Tumour size (cm)
<5	10	9	0.107
≥5	12	27
AFP (ng/mL)
<20	9	11	0.421
≥20	13	25
TNM stage
I + II	13	8	0.005
III + IV	9	28
HBV infection
No	9	10	0.863
Yes	13	16
Cirrhosis
No	15	12	0.01
Yes	7	24
Metastasis
No	10	7	0.035
Yes	12	29

The low and high is graded by comparison of the mean Normal IHC scoring. Statistically significant (), Statistically significant (). Statistically significant ().